Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
225.4 USD | -2.83% | +0.22% | -12.88% |
01:00pm | US FDA advisers to review Eli Lilly Alzheimer's drug | RE |
09:44am | Biogen, Eisai Say Alzheimer's Maintenance Treatment Application Accepted by US FDA | MT |
Financials (USD)
Sales 2024 * | 9.52B | Sales 2025 * | 9.56B | Capitalization | 32.82B |
---|---|---|---|---|---|
Net income 2024 * | 1.94B | Net income 2025 * | 2.26B | EV / Sales 2024 * | 3.76 x |
Net Debt 2024 * | 2.99B | Net Debt 2025 * | 614M | EV / Sales 2025 * | 3.5 x |
P/E ratio 2024 * |
17.4
x | P/E ratio 2025 * |
14.9
x | Employees | 7,570 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 85.81% |
Latest transcript on Biogen Inc.
1 day | -2.83% | ||
1 week | +0.22% | ||
Current month | +0.22% | ||
1 month | +1.20% | ||
3 months | +0.98% | ||
6 months | -5.79% | ||
Current year | -12.88% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 64 | 22-11-13 | |
Director of Finance/CFO | 60 | 20-08-14 | |
Nicole Murphy
COO | Chief Operating Officer | - | 14-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Stephen Sherwin
BRD | Director/Board Member | 75 | 09-12-31 |
William Hawkins
BRD | Director/Board Member | 70 | 19-06-18 |
Caroline Dorsa
CHM | Chairman | 64 | 10-01-02 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
4.30% | 1 M€ | +0.84% | - | |
3.92% | 0 M€ | 0.00% | - | |
3.75% | 0 M€ | 0.00% | - | |
2.39% | 13,503 M€ | +4.43% |
Date | Price | Change | Volume |
---|---|---|---|
24-06-07 | 225.4 | -2.83% | 958,650 |
24-06-06 | 232 | -2.00% | 887,370 |
24-06-05 | 236.7 | +1.11% | 947,930 |
24-06-04 | 234.1 | +1.88% | 1,016,693 |
24-06-03 | 229.8 | +2.16% | 1,220,813 |
Delayed Quote Nasdaq, June 07, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-12.88% | 32.82B | |
+0.82% | 91.94B | |
-1.32% | 38.74B | |
+64.45% | 26.66B | |
-16.31% | 15.32B | |
-11.38% | 11.65B | |
+173.10% | 10.37B | |
-49.84% | 10.12B | |
+4.34% | 9.06B | |
-16.26% | 7.46B |
- Stock Market
- Equities
- BIIB Stock